Nevi and Melanomas: Clinical Trials

3,429 trials for Nevi and Melanomas, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1620 completed, 529 terminated, 424 recruiting, 333 unknown. 1413 Phase 2, 1262 Phase 1, 372 Not applicable, 200 Phase 3, 60 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 21413Completed 638, Terminated 271, Recruiting 158, Unknown 127, Active not recruiting 111, Withdrawn 67, Not yet recruiting 32, Suspended 8, Enrolling by invitation 1
Phase 11262Completed 598, Terminated 253, Recruiting 143, Active not recruiting 96, Unknown 96, Withdrawn 49, Not yet recruiting 14, Suspended 10, Enrolling by invitation 3
Not applicable372Completed 185, Recruiting 69, Unknown 45, Terminated 21, Active not recruiting 20, Not yet recruiting 17, Withdrawn 10, Suspended 3, Enrolling by invitation 2
Phase 3200Completed 89, Active not recruiting 30, Recruiting 28, Terminated 28, Unknown 19, Withdrawn 4, Not yet recruiting 2
Early Phase 160Completed 25, Terminated 12, Recruiting 7, Not yet recruiting 5, Active not recruiting 4, Withdrawn 4, Unknown 3
Phase 432Completed 13, Unknown 7, Not yet recruiting 4, Terminated 3, Recruiting 2, Withdrawn 2, Active not recruiting 1

Follow Nevi and Melanomas: new trials by email Literature Review of Nevi and Melanomas trials Research Report on Nevi and Melanomas

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination Immunotherapy Targeting Melanoma
Antigen-specific CAR T, CTL and DCvac to treat melanoma. - Melanoma
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute302027-06-302026-10-30
Trial of Temozolomide in BAP1 Mutated Patients With Advanced or Metastatic Cutaneous Melanoma
Temozolomide (TMZ) - Cutaneous Melanoma
Phase 2Not yet recruitingAssistance Publique Hopitaux De Marseille282027-06-012026-09-08
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Biospecimen Collection, Chest Radiography, Computed Tomography - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8
Phase 2RecruitingChildren's Oncology Group512027-05-152026-09-24
Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma
RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior to RAPA-201 Therapy - Malignant Melanoma With Metastasis, Malignant Melanoma
Phase 2Not yet recruitingRapa Therapeutics LLC652027-03-012026-03-19
A Pilot Study to Examine the Efficacy and Tolerability of Sirolimus on Epidermal Nevi Lesions in Patients 6 Years Old and Above.
sirolimus topical gel 0.2% - Epidermal Nevi
Early Phase 1Not yet recruitingNorthwestern University142027-02-012026-11-09
Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases
Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2 - Uveal Melanoma, Metastatic Cutaneous Melanoma
Phase 1Not yet recruitingVastra Gotaland Region62027-01-312026-09-09
Mirdametinib to Reduce the Size of Large/Giant Congenital Melanocytic Nevi in Children, Adolescents and Young Adults
Mirdametinib - LGCMN, Large and Giant Congenital Melanocytic Nevi
Phase 2Not yet recruitingNational Cancer Institute (NCI)152027-01-042026-10-29
Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma
Autologous Tumor Infiltrating Lymphocytes (TIL), Melphalan, Interleukin-2 - Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma
Phase 1Not yet recruitingVastra Gotaland Region182027-01-012026-09-09
A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.
Signatera Genome ultra-sensitive ctDNA blood test - NSCLC (Advanced Non-small Cell Lung Cancer), NSCLC (Non-small Cell Lung Cancer)
Not applicableNot yet recruitingNatera, Inc.9202027-01-012026-10-27
Development of an Aid to Melanoma Detection Using Artificial Intelligence Algorithms Based on Images From the VECTRA 3D System.
Scanner of the whole body using the VECTRA 3D - Naevi
Not applicableNot yet recruitingAssistance Publique Hopitaux De Marseille10002027-01-012026-10-28
Study of ACC-1898 in Adult Participants With Advanced Solid Tumors
ACC-1898 - Hepatocellular Carcinoma, Renal Cell Carcinoma
Phase 1Not yet recruitingAccSalus Biosciences, Inc.402027-01-012026-10-28
Prospective, Multi-Center Observational Registry of Melanoma CP-GEP and Clinical Outcomes
Melanoma (Skin Cancer), Gene Expression Profiling
Not yet recruitingSkylineDx20002027-01-012026-11-13
Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
ICI Therapy - Gastrointestinal Neoplasms, Genitourinary Cancer
Early Phase 1Not yet recruitingIndiana University802027-01-012026-11-18
Neoadjuvant RP2 + Nivolumab in Patients With Melanoma
RP2 (vusolimogene oderparepvec), Nivolumab, Definitive Surgical Resection - MelanomaCutaneous Melanoma Resectable, Melanoma
Phase 2Not yet recruitingYana Najjar342026-12-312026-10-07
Trial Comparing CPDMA Versus Standard Breadloafing in WLE Specimens of Stage 1-II Cutaneous Melanoma
Wide Local Excision - Cutaneous Melanoma, Stage II, Cutaneous Melanoma
Not applicableNot yet recruitingUniversity of Nebraska2822026-12-242026-10-09
Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte Therapy
Biospecimen Collection, Internet-Based Intervention, Medical Device Usage and Evaluation - Advanced Cutaneous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8
Phase 1Not yet recruitingCity of Hope Medical Center82026-12-232026-06-05
Biomechanical Characterization of Skin Properties Using Impact Based-Analysis Method (IBAM)
Melanoma (Skin Cancer), Skin Carcinoma
Not yet recruitingCentre Hospitalier Universitaire Henri Mondor, Assistance Publique Hôpitaux de Paris102026-12-032026-10-06
Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial
Internet-Based Intervention, Interview, Questionnaire Administration - Differentiated Thyroid Gland Carcinoma, Malignant Testicular Neoplasm
Not applicableNot yet recruitingUniversity of Michigan Rogel Cancer Center1422026-12-012026-10-15
Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma
Fianlimab, Cemiplimab - Melanoma (Skin)
Phase 2Not yet recruitingUniversity of California, Irvine352026-12-012026-09-11
iSCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable Melanoma
iSCIB1+, Nivolumab & Ipilimumab, Placebo - Melanoma (Skin Cancer), Advanced Melanoma
Phase 3Not yet recruitingScancell Ltd5502026-12-012026-09-11

Showing 20 of 3429. Sign in to see all of them.

Narrower conditions

Melanoma (3205)  ·  Carcinoma, Non-Small-Cell Lung (411)  ·  Neoplasms (315)  ·  Carcinoma, Renal Cell (297)  ·  Breast Neoplasms (292)  ·  Neoplasm Metastasis (290)  ·  Uveal Melanoma (280)  ·  Colorectal Neoplasms (224)  ·  Skin Neoplasms (214)  ·  Lung Neoplasms (213)  ·  Ovarian Neoplasms (191)  ·  Sarcoma (173)  ·  Squamous Cell Carcinoma of Head and Neck (168)  ·  Pancreatic Neoplasms (159)  ·  Head and Neck Neoplasms (144)

Broader conditions

Neoplasms by Histologic Type (3420)  ·  Neoplasms, Nerve Tissue (3380)  ·  Neuroectodermal Tumors (3380)  ·  Neoplasms by Site (3374)  ·  Neoplasms, Germ Cell and Embryonal (3370)  ·  Neuroendocrine Tumors (3368)  ·  Skin and Connective Tissue Diseases (3239)  ·  Skin Diseases (3226)  ·  Neoplasms (3114)  ·  Skin Neoplasms (3007)  ·  Neoplasms, Glandular and Epithelial (654)  ·  Urogenital Diseases (584)  ·  Respiratory Tract Diseases (582)  ·  Thoracic Neoplasms (582)

Interventions

pembrolizumab (311)  ·  Nivolumab (292)  ·  Ipilimumab (270)  ·  Cyclophosphamide (142)  ·  aldesleukin (141)  ·  Interleukin-2 (109)  ·  trametinib (85)  ·  Dacarbazine (81)  ·  Temozolomide (80)  ·  dabrafenib (77)  ·  Vemurafenib (71)  ·  fludarabine (69)  ·  fludarabine phosphate (63)  ·  Biopsy (53)  ·  binimetinib (48)

Sponsors

National Cancer Institute (NCI) (218)  ·  M.D. Anderson Cancer Center (104)  ·  Bristol-Myers Squibb (90)  ·  Memorial Sloan Kettering Cancer Center (68)  ·  Novartis Pharmaceuticals (47)  ·  Hoffmann-La Roche (45)  ·  H. Lee Moffitt Cancer Center and Research Institute (43)  ·  Mayo Clinic (42)  ·  Pfizer (38)  ·  Merck Sharp & Dohme LLC (35)  ·  GlaxoSmithKline (28)  ·  Dana-Farber Cancer Institute (26)  ·  Peking University Cancer Hospital & Institute (25)  ·  University Health Network, Toronto (20)  ·  Craig L Slingluff, Jr (19)

Countries

United States (2108)  ·  France (371)  ·  Australia (287)  ·  Germany (286)  ·  Spain (284)  ·  United Kingdom (275)  ·  Italy (268)  ·  Canada (241)  ·  Netherlands (179)  ·  China (164)  ·  Belgium (158)  ·  Switzerland (152)  ·  Poland (110)  ·  Israel (109)  ·  Sweden (95)

Top investigators

Steven A Rosenberg, M.D. (29)  ·  Steven A. Rosenberg, MD, PhD (27)  ·  F. Stephen Hodi, MD (14)  ·  Paul Chapman, MD (10)  ·  Craig L Slingluff, MD (9)  ·  Craig L. Slingluff, MD (9)

Results publications

PMID 36648215, PMID 25667295, PMID 24983357, PMID 39504507, PMID 22555974, PMID 22256804, PMID 25649350, PMID 26446943, PMID 31395089, PMID 32746839, PMID 23457002, PMID 23861247, PMID 24408395, PMID 24577748, PMID 27864013, PMID 30202085, PMID 30736858, PMID 31401903, PMID 32305010, PMID 32747469, PMID 33360855, PMID 34225229, PMID 34754076, PMID 36653848, PMID 39462179, PMID 40721981, PMID 41811823, PMID 20856802, PMID 21600759, PMID 21639810, PMID 23054107, PMID 23295794, PMID 23504141, PMID 24145345, PMID 24418949, PMID 24695685, PMID 25432172, PMID 25837513, PMID 26902923, PMID 28592387, PMID 28662232, PMID 29528792, PMID 29896663, PMID 31166680, PMID 31406564, PMID 31864178, PMID 32303612, PMID 32350119, PMID 32596742, PMID 33444116

NIH funding

2023 (40), 2019 (28), 2016 (23), 2018 (23), 2015 (16), 2014 (15), 2025 (13), P30CA015083 (13), P30CA072720 (12), U10CA032102 (12), 2009 (11), U10CA180820 (11), 2008 (10), P30CA016672 (10), P30CA008748 (9)